Disease Info Card

Advanced Malignant Neoplasm

Information about Advanced Malignant Neoplasm: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Advanced Malignant Neoplasm

Most recent studies have shown that Advanced Malignant Neoplasm shares some biological mechanisms with adenocarcinoma, carcinoma, colorectal-cancer, depressive-disorder, locally-advanced-malignant-neoplasm, lung-neoplasms, malignant-neoplasm-of-breast, malignant-neoplasm-of-lung, malignant-neoplasm-of-prostate, malignant-neoplasm-of-stomach, malignant-neoplasms, malignant-paraganglionic-neoplasm, malignant-squamous-cell-neoplasm, mammary-neoplasms, nausea, neoplasm-metastasis, neoplasms, pain, stomach-neoplasms, vomiting.

Among the many pathways, these few ones have gauged particular interests from scientists studying Advanced Malignant Neoplasm, and have been seen in publications frequently: Aging, Angiogenesis, Bone Resorption, Cell Adhesion, Cell Cycle, Cell Death, Cell Growth, Cell Proliferation, Circadian Rhythm, Coagulation, Cytokine Production, Drug Resistance, Excretion, Hypersensitivity, Immune Response, Inflammatory Response, Localization, Methylation, Pathogenesis, Secretion

Quite a number of genes have been found to play important roles in Advanced Malignant Neoplasm, such as ALB, ALPK1, ARL4C, CDAN1, CRP, CTLA4, EGFR, IFNG, IL10, IL2, IL6, KLK3, PGR, PSAT1, SLC25A5, TMEM37, TNF, VEGFA. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.